| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lexaria Bioscience Corp. | Director | common shares | 13,000 | $15,860 | $1.22 | 15 May 2025 | Direct |
| Lexaria Bioscience Corp. | Director | Stock Options | 11,000 | 15 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LEXX | Lexaria Bioscience Corp. | 15 May 2025 | 1 | $0 | 4 | Director | 16 May 2025, 16:44 |
| LEXX | Lexaria Bioscience Corp. | 14 Jan 2025 | 0 | $0 | 3 | Director | 16 Jan 2025, 11:39 |
| DMN | Damon Inc. | 13 Nov 2024 | 0 | $0 | 3 | Chief Financial Officer, Director | 15 Nov 2024, 19:51 |